A
Aldosterone antagonist 496
Angiotensin receptor blockers, use of 187
Anomalous coronary arteries 505
Antiarrhythmic trial with dronedarone 63
Aortic and right atrial pressures 507f
Arrhythmic right ventricular dysplasia (ARVD) 251f
Arrhythmogenic cardiomyopathy, left dominant 286
Atherosclerotic disease 453
ablation 188f
classification of 169
etiology of 172
factors predisposing to 173t
genetic causes of 178t
incidence of 170
investigators 191
maintenance of 181
pathogenesis of 172
prevalence of 170
Atrial inflammation, causes of 189
Atrial tachyarrhythmias 174
Atrioventricular conduction disease, evaluation of 113
Atrioventricular nodal dependent SVT 214
Atrioventricular nodal independent SVT 230
Atrioventricular node disease 272
Atropine 470
Automatic implantable cardioverter defibrillator 465
Autosomal dominant disease 286
B
Beta-adrenoceptor blockers 46
Bidirectional tachycardia 254
Blood tests 138
Brain natriuretic peptide levels 138
Bundle branch block 276
C
Calcium channel antagonists 66
Cardiac access and catheterization 91
Cardiac arrest 517
and resuscitation 450
etiology of 505
guidelines for primary 512
pathophysiology of 505
reversible causes of 468t
Cardiac arrhythmia suppression trial 44
Cardiac catheterization 149
Cardiac conduction system, development of 268
Cardiac electrophysiology for evaluation of drug therapy 123
Cardiac interventions 480
Cardiac nervous system dysfunction 175
Cardiac pump model of cardiopulmonary resuscitation 452f
Cardiac refractory, determination of 104f
Cardiac ryanodine receptor 288
Cardiac sympathetic denervation, left 319
Cardiac transplantation 269
Cardiac-surgical ablation 332
Cardiac-surgical contribution 336
Cardioactive agents 121
Cardiomyocytes 284
Cardiomyopathy, dilated 290
Cardiopulmonary arrest 453
chain of survival 504f
complications of 466
compression only 462
dispatcher assisted 462
thoracic pump model of 452f
Cardiopulmonary support 479
Cardioversion 471
Cardioverter defibrillator
automatic implantable 465
implantable 120
therapy, implantable 318
trial, alternans before 497
Carotid sinus massage (CSM) 137
Carvajal syndrome 299
complications of 339
development of 336
efficacy of 341
for SVT, complications of 235t
of AVNRT 334
techniques of 340
Cavotricuspid isthmus (CTI) 347
Cerebral perfusion 506
Chest compressions 463
Commotio cordis 505
COMPANION study 394
Conduction system disease 175
Congenital long QT interval syndrome 254
Consciousness and syncope, classification of 131fc
CONTAK-cardiac defibrillator (CONTAK-CD) 397
Continuous pacing 101
CRT
and ventricular arrhythmias 411
benefit 398
complications 409
device, optimization of 401
for acute decompensated heart failure 416
in practice 391
indications, emerging 411
CTI dependent AFLs, ablation of 343
Cusp VT 367
D
Defibrillation 471
Defibrillator in
acute myocardial infarction trial (DINAMIT) 496
nonischemic cardiomyopathy treatment evaluation (DEFINITE) trial 154
Desmoplakin gene (DSP) 282
Desmosomal dysfunction 284
Desmosome function 283
Desmosome structure 283
Digoxin 228
Diltiazem 227
Disease severity, different phases of 290t
Disopyramide 40
Dronedarone 57
Drug therapy, electrophysiology study 90t
Dual atrioventricular node 112f
Dyssynchrony imaging, role of 402
E
Ectopy, atrial 30
Electroanatomic three-dimensional mapping 357
Electrocardiogram 84
Electrocardiographic monitoring 49
Electrophysiological abnormalities 175
Emergency medical technician-basic (EMT-B) 458
Emergency medical technician-intermediate (EMT-I) 458
EMS provider levels 460t
Endomyocardial biopsy 295
Epinephrine 469
Esmolol 228
Excessive ventilation, consequence of 524f
H
Heart transplant 400
Hematocrit 138
Hemoglobin 138
His-Purkinje disease 113f
Holter monitoring 432
Hypersensitive carotid sinus syndrome 419
Hypotension, symptomatic 190
Hypoxia 130
I
Iatrogenic VT 254
ICD shock and defibrillation 247f
Implantable cardioverter-defibrillator study 495
Intra-atrial re-entrant tachycardia 212
Intracardiac channels 104f
Intraventricular conduction defect 248
Intraventricular dyssynchrony 393
Ion channel and cellular properties, consequence of 10
Ion channel proteins, mutation in 19t
Ischemia, active 258
Ischemic-related PVT-VF 258
L
Lange-Nielsen syndrome 310
Laryngeal mask airway 458
Lethal arrhythmia syndrome 326
Lower pulmonary vein, left 348
Lung disease 453
LV systolic dysfunction 173
M
Mahaim fiber 219
Marfan syndrome 493
Metoprolol 227
Minimally symptomatic heart failure 415
Miracle study 394
Mitral annular VT 374
Mitral cusp VT 254
Mitral regurgitation 400
Mitral valve prolapse 493
Multielectrode catheters, diagnostic 92f
Multiple gated acquisition scan 409
Myocardial adenosine triphosphate 519
Myocardial cells 7f
Myocardial hypertrophy 259
Myocardial tissue 12f
N
Naxos disease 299
New task force criteria 292t
New-onset atrial fibrillation 181
Normal cardiac electrophysiology 95
North American Azimilide Cardioversion Maintenance Trial 66
P
Pace mapping 358
Paroxysmal AV block 274
Phrenic nerve simulation 410
Pill-in-the-pocket approach 185
Posterior fascicular block, left 374
Post-resuscitation care 479
Proarrhythmia 30
Propafenone 45
Psychogenic reaction, response of 146
Pulmonary artery 366
Pulmonary disease or hypertension 169
Pulmonary veins 211
Pulmonary venous activity 175
Q
QRS complex tachycardias, electrophysiology study 87t
QRS tachycardia, differential diagnosis of wide 224t
QT intervals, electrophysiology study 88t
Quinidine 39
R
RAAS system, modulators of 187
Ranolazine 70
Real-time three-dimensional echocardiography 408
Re-entrant tachycardia 354
Renin-angiotensin-aldosterone system 176
Repolarization, early 491
Rescue breathing 509
Resuscitation, cessation of 478
Rhythm disorders 422
Right atrial disease 490
Right lower pulmonary vein 348
S
Saw tooth 210f
Selective serotonin receptor inhibitors 152
Shockable rhythm 513
Sicilian gambit for classifying antiarrhythmic drugs 33f
Sick sinus syndrome 271
Sinoatrial conduction time 110
Sinoatrial re-entry tachycardia 212
Sinus bradycardia 30
Sinus node disease 271
Sinus tachycardia 208
Situational syncope 134
Sodium calcium exchanger 311
Sodium channel blockers 34
Sodium channel gene 319
Sotalol renal dosing algorithm 48t
Spontaneous circulation, return of 450
Spontaneous ventricular tachycardia 246f
SQT syndrome 320
Strain rate imaging 404
Sudden cardiac arrest, survivors of 119
Sudden unexplained death in sleep 322
Sudden unexplained nocturnal deaths 322
Superior vena cava 175
classification of 133
diagnostic evaluation of 150fc
economic burden of 132
incidence of 131
prevalence of 131
trial, prevention of 152
unexplained 89t
Systolic blood pressure 145f
Systolic heart failure, treatment of 390
T
Three-dimensional mapping systems, role of 123
Thromboembolism, prevention of 191
Trauma systems 456
Tricuspid annular VT 375
V
Vagal tone 268
Valsalva, aortic sinus of 254
Vasopressin 469
Vasovagal reactions 269
Ventricular assist device 400
Ventricular dysfunction 172
Ventricular ejection fractions 248
Ventricular end-diastolic volumes 415
Ventricular end-systolic volumes 415
Ventricular outflow tract 365
Ventricular pre-excitation and AVNRT, evolution of 336
Voltage-gated calcium channel 314